A reversible monoamine oxidase inhibitor, Toloxatone: comparison of its physicochemical properties with those of other inhibitors including Brofaromine, Harmine, R40519 and Moclobemide

Author： Moureau F.   Wouters J.   Depas M.   Vercauteren D.   Durant F.   Ducrey F.   Koenig J.   Jarreau F.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.30, Iss.11, 1995-01, pp. : 823-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pirlindole: A Selective Reversible Inhibitor of Monoamine Oxidase a. A Review of Its Preclinical Properties

By Bruhwyler J.   Liegeois J.F.   Geczy J.  

Pharmacological Research, Vol. 36, Iss. 1, 1997-07 ,pp. : 23-33

Academic Press

Access to resources Recommend Favorite

Leflunomide, a Reversible Monoamine Oxidase Inhibitor

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 2, 2016-08 ,pp. : 112-119

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

By Haddjeri N.   De Montigny C.   Curet O.   Blier P.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 179-192

Elsevier

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S.   George P.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

Focusing on new monoamine oxidase inhibitors

By Bolasco Adriana   Carradori Simone   Fioravanti Rossella  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 909-939

Informa Healthcare

Access to resources Recommend Favorite